Home » Newsletters » BioWorld

BioWorld

Jan. 6, 1993

View Archived Issues

PROCYTE FILES FOR OFFERING

SCICLONE'S HEPATITIS DRUG ENTERS PHASE III

LIPOSOME TECH FILES PLA IN U.K.

EYE TREATMENT DESIGNATED ORPHAN DRUG

GENTA FILES IND FOR DERMATOLOGICAL DRUG

ECOGEN CROSS-LICENSING PACT IN AUSTRALIA

CALGENE ASKS FDA TO RULE ON GENE

DRUG APPROVALS: FEW AND FAR BETWEEN

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...